Literature DB >> 24474686

Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.

Tatiana Brustovetsky1, Jessica J Pellman, Xiao-Fang Yang, Rajesh Khanna, Nickolay Brustovetsky.   

Abstract

Collapsin response mediator protein 2 (CRMP2) is traditionally viewed as an axonal growth protein involved in axon/dendrite specification. Here, we describe novel functions of CRMP2. A 15-amino acid peptide from CRMP2, fused to the TAT cell-penetrating motif of the HIV-1 protein, TAT-CBD3, but not CBD3 without TAT, attenuated N-methyl-d-aspartate receptor (NMDAR) activity and protected neurons against glutamate-induced Ca(2+) dysregulation, suggesting the key contribution of CRMP2 in these processes. In addition, TAT-CBD3, but not CBD3 without TAT or TAT-scramble peptide, inhibited increases in cytosolic Ca(2+) mediated by the plasmalemmal Na(+)/Ca(2+) exchanger (NCX) operating in the reverse mode. Co-immunoprecipitation experiments revealed an interaction between CRMP2 and NMDAR as well as NCX3 but not NCX1. TAT-CBD3 disrupted CRMP2-NMDAR interaction without change in NMDAR localization. In contrast, TAT-CBD3 augmented the CRMP2-NCX3 co-immunoprecipitation, indicating increased interaction or stabilization of a complex between these proteins. Immunostaining with an anti-NCX3 antibody revealed that TAT-CBD3 induced NCX3 internalization, suggesting that both reverse and forward modes of NCX might be affected. Indeed, the forward mode of NCX, evaluated in experiments with ionomycin-induced Ca(2+) influx into neurons, was strongly suppressed by TAT-CBD3. Knockdown of CRMP2 with short interfering RNA (siRNA) prevented NCX3 internalization in response to TAT-CBD3 exposure. Moreover, CRMP2 down-regulation strongly attenuated TAT-CBD3-induced inhibition of reverse NCX. Overall, our results demonstrate that CRMP2 interacts with NCX and NMDAR and that TAT-CBD3 protects against glutamate-induced Ca(2+) dysregulation most likely via suppression of both NMDAR and NCX activities. Our results further clarify the mechanism of action of TAT-CBD3 and identify a novel regulatory checkpoint for NMDAR and NCX function based on CRMP2 interaction with these proteins.

Entities:  

Keywords:  CRMP2; Calcium Signaling; Glutamate; Glutamate Receptors; NMDA Receptor; Neurons; Sodium Calcium Exchange; TAT-CBD3

Mesh:

Substances:

Year:  2014        PMID: 24474686      PMCID: PMC3953261          DOI: 10.1074/jbc.M113.518472

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells.

Authors:  S L Budd; D G Nicholls
Journal:  J Neurochem       Date:  1996-12       Impact factor: 5.372

2.  Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking.

Authors:  Penelope J Hallett; Robert Spoelgen; Bradley T Hyman; David G Standaert; Anthone W Dunah
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

3.  Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors.

Authors:  Miou Zhou; Michel Baudry
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

4.  Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity.

Authors:  Ruslan I Stanika; Natalia B Pivovarova; Christine A Brantner; Charlotte A Watts; Christine A Winters; S Brian Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

5.  Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.

Authors:  Joel M Brittain; Yuying Wang; Omotore Eruvwetere; Rajesh Khanna
Journal:  FEBS Lett       Date:  2012-09-26       Impact factor: 4.124

6.  KB-R7943, an inhibitor of the reverse Na+ /Ca2+ exchanger, blocks N-methyl-D-aspartate receptor and inhibits mitochondrial complex I.

Authors:  Tatiana Brustovetsky; Matthew K Brittain; Patrick L Sheets; Theodore R Cummins; Vsevolod Pinelis; Nickolay Brustovetsky
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

7.  Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.

Authors:  H Manev; M Favaron; A Guidotti; E Costa
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

8.  Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death.

Authors:  Viacheslav Li; Tatiana Brustovetsky; Nickolay Brustovetsky
Journal:  Exp Neurol       Date:  2009-02-21       Impact factor: 5.330

9.  Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Authors:  Rajesh Khanna; Sarah M Wilson; Joel M Brittain; Jill Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Journal:  Future Neurol       Date:  2012-11-01

10.  Glutamate impairs neuronal calcium extrusion while reducing sodium gradient.

Authors:  L Kiedrowski; G Brooker; E Costa; J T Wroblewski
Journal:  Neuron       Date:  1994-02       Impact factor: 17.173

View more
  33 in total

1.  Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.

Authors:  Bruno P Meloni; Laura M Brookes; Vince W Clark; Jane L Cross; Adam B Edwards; Ryan S Anderton; Richard M Hopkins; Katrin Hoffmann; Neville W Knuckey
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

2.  Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Authors:  Jie Yu; Aubin Moutal; Angie Dorame; Shreya S Bellampalli; Aude Chefdeville; Iori Kanazawa; Nancy Y N Pham; Ki Duk Park; Jill M Weimer; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2018-12-18       Impact factor: 5.590

3.  AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain.

Authors:  Hongwei Yu; Seung Min Shin; Hongfei Xiang; Dongman Chao; Yongsong Cai; Hao Xu; Rajesh Khanna; Bin Pan; Quinn H Hogan
Journal:  Gene Ther       Date:  2019-05-22       Impact factor: 5.250

4.  Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.

Authors:  Adam B Edwards; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Cell Biochem       Date:  2016-11-14       Impact factor: 3.396

Review 5.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

6.  Inhibition of N-Methyl-D-aspartate-induced Retinal Neuronal Death by Polyarginine Peptides Is Linked to the Attenuation of Stress-induced Hyperpolarization of the Inner Mitochondrial Membrane Potential.

Authors:  John Marshall; Kwoon Y Wong; Chamila N Rupasinghe; Rakesh Tiwari; Xiwu Zhao; Eren D Berberoglu; Christopher Sinkler; Jenney Liu; Icksoo Lee; Keykavous Parang; Mark R Spaller; Maik Hüttemann; Dennis J Goebel
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

7.  Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.

Authors:  Bruno P Meloni; Diego Milani; Jane L Cross; Vince W Clark; Adam B Edwards; Ryan S Anderton; David J Blacker; Neville W Knuckey
Journal:  Neuromolecular Med       Date:  2017-05-18       Impact factor: 3.843

8.  Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.

Authors:  Aubin Moutal; Wennan Li; Yue Wang; Weina Ju; Shizhen Luo; Song Cai; Liberty François-Moutal; Samantha Perez-Miller; Jackie Hu; Erik T Dustrude; Todd W Vanderah; Vijay Gokhale; May Khanna; Rajesh Khanna
Journal:  Br J Pharmacol       Date:  2017-03-17       Impact factor: 8.739

9.  The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.

Authors:  Gabriella MacDougall; Ryan S Anderton; Adam B Edwards; Neville W Knuckey; Bruno P Meloni
Journal:  J Mol Neurosci       Date:  2016-11-20       Impact factor: 3.444

10.  Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.

Authors:  Erik T Dustrude; Aubin Moutal; Xiaofang Yang; Yuying Wang; May Khanna; Rajesh Khanna
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.